Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1048525112 | 10485251 | 12 | F | 20141006 | 20160819 | 20140930 | 20160826 | EXP | PHHY2014CA092142 | NOVARTIS | 52.06 | YR | M | Y | 0.00000 | 20160826 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1048525112 | 10485251 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | Y | 21588 | 400 | MG | QD | ||||||
| 1048525112 | 10485251 | 2 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 400 MG, QD | Y | 21588 | 400 | MG | QD | ||||||
| 1048525112 | 10485251 | 3 | SS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 200 MG, QD | Y | 21588 | 200 | MG | QD | ||||||
| 1048525112 | 10485251 | 4 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Unknown | PRN | U | 0 | |||||||||
| 1048525112 | 10485251 | 5 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Unknown | UNK, PRN | U | 0 | |||||||||
| 1048525112 | 10485251 | 6 | C | LOSEC /CAN/ | 2 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1048525112 | 10485251 | 1 | Gastrointestinal stromal tumour |
| 1048525112 | 10485251 | 4 | Musculoskeletal pain |
| 1048525112 | 10485251 | 5 | Product used for unknown indication |
| 1048525112 | 10485251 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1048525112 | 10485251 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1048525112 | 10485251 | Asthenia | |
| 1048525112 | 10485251 | Drug intolerance | |
| 1048525112 | 10485251 | Dry mouth | |
| 1048525112 | 10485251 | Fatigue | |
| 1048525112 | 10485251 | Feeling abnormal | |
| 1048525112 | 10485251 | Haemoglobin decreased | |
| 1048525112 | 10485251 | Haemoglobin increased | |
| 1048525112 | 10485251 | Hiccups | |
| 1048525112 | 10485251 | Hypersensitivity | |
| 1048525112 | 10485251 | Hypotension | |
| 1048525112 | 10485251 | Muscular weakness | |
| 1048525112 | 10485251 | Nausea | |
| 1048525112 | 10485251 | Pain | |
| 1048525112 | 10485251 | Poor quality sleep | |
| 1048525112 | 10485251 | Prescribed underdose | |
| 1048525112 | 10485251 | Pyrexia | |
| 1048525112 | 10485251 | Rash generalised | |
| 1048525112 | 10485251 | Red blood cell count decreased | |
| 1048525112 | 10485251 | Stomatitis | |
| 1048525112 | 10485251 | Tongue haemorrhage | |
| 1048525112 | 10485251 | Tumour compression | |
| 1048525112 | 10485251 | Tumour rupture | |
| 1048525112 | 10485251 | Urticaria | |
| 1048525112 | 10485251 | Venous occlusion | |
| 1048525112 | 10485251 | Vitamin D decreased | |
| 1048525112 | 10485251 | Volvulus | |
| 1048525112 | 10485251 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1048525112 | 10485251 | 1 | 20140715 | 20141006 | 0 |